z-logo
open-access-imgOpen Access
Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
Author(s) -
Xian Xiao,
Guixing Zhang,
Binxu Sun,
Chaoran Wang,
Xiaoqun Wang,
Fanming Kong,
Yingjie Jia
Publication year - 2022
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr-22-71
Subject(s) - bevacizumab , medicine , biosimilar , oncology , lung cancer , carboplatin , meta analysis , randomized controlled trial , adverse effect , cochrane library , chemotherapy , cisplatin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom